author-photo

Julio C. Rojas

University of California, San Francisco
University of Texas at Austin

72

Papers

2507

Citations

Citation Trend

Filter By

Papers (54) Sort By

Journal Conference Others

Selective vulnerability to atrophy in sporadic Creutzfeldt-Jakob disease.

2021 Annals of clinical and translational neurology
Show All
- Source
- Cite
- Save
Citations (0)
Lower White Matter Volume and Worse Executive Functioning Reflected in Higher Levels of Plasma GFAP among Older Adults with and Without Cognitive Impairment.

2021 Journal of The International Neuropsychological Society
Show All
- Source
- Cite
- Save
Citations (0)
Effect of the Histone Deacetylase Inhibitor FRM-0334 on Progranulin Levels in Patients With Progranulin Gene Haploinsufficiency: A Randomized Clinical Trial.

2021
Show All
- Source
- Cite
- Save
Citations (0)
Impact of cortical and subcortical atrophy in the diagnosis and prognosis of bvFTD: A multicenter longitudinal study: Neuroimaging / Optimal neuroimaging measures for tracking disease progression

2020 Alzheimers & Dementia
Show All
- Source
- Cite
- Save
Citations (0)
Open‐Label Phase 1 Futility Studies of Salsalate and Young Plasma in Progressive Supranuclear Palsy

2020 Movement Disorders Clinical Practice
Show All
- Source
- Cite
- Save
Citations (15)
Comparative diagnostic performance of plasma P‐tau217 and P‐tau181 in Alzheimer’s disease and frontotemporal lobar degeneration and correlations with [18F]Flortaucipir‐PET uptake: Biomarkers (non‐neuroimaging)/Plasma/Serum/Urine biomarkers

2020 Alzheimers & Dementia
Show All
- Source
- Cite
- Save
Citations (0)
Lipid metabolism dysfunction in progranulin mutation carriers: Unbiased metabolomics reveals strong relationship to clinical status in FTLD: Biomarkers (non‐neuroimaging)/Use in clinical trial design and evaluation

2020 Alzheimers & Dementia
Show All
- Source
- Cite
- Save
Citations (0)
Latent disease models estimate symptom onset in familial frontotemporal lobar degeneration and enable novel designs for early‐stage clinical trials: Developments in clinical, radiological and biomarker measurements for the detection and monitoring of early‐stage frontotemporal dementia and implications for treatment development

2020 Alzheimers & Dementia
Show All
- Source
- Cite
- Save
Citations (0)
Latent disease models estimate symptom onset in familial frontotemporal lobar degeneration and enable novel designs for early-stage clinical trials

2020
Show All
- Source
- Cite
- Save
Citations (0)
Plasma Glial Fibrillary Acidic Protein Levels Differ Along the Spectra of Amyloid Burden and Clinical Disease Stage

2020 Journal of Alzheimer's Disease
Show All
- Source
- Cite
- Save
Citations (8)